SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (347)7/27/1999 10:01:00 PM
From: WTDEC  Read Replies (1) | Respond to of 3044
 
It couldn't possibly be these mighty mice....

Lexicon Genetics Announces Agreement With Millennium Pharmaceuticals
Marks Lexicon's 9th Corporate Collaboration for Knockout Mouse Creation
THE WOODLANDS, Texas, July 27 /PRNewswire/ -- Lexicon Genetics Incorporated announced today the signing of a multi-year agreement with Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM - news). Under the agreement, Lexicon will use its portfolio of proprietary homologous recombination technologies to create genetically-engineered mice for use by Millennium in the validation of potential drug targets identified and selected by Millennium
-< SNIP